| Year |
Citation |
Score |
| 2019 |
Passwell JH, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, Even-Nir H, Yerushalmi B, Chu C, Shiloach J, Robbins JB, Schneerson R. Erratum to 'Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children' [Vaccine 28 (2010) 2231-2235]. Vaccine. PMID 31378536 DOI: 10.1016/J.Vaccine.2019.07.065 |
0.611 |
|
| 2017 |
Farzam N, Ramon-Saraf R, Banet-Levi Y, Lerner-Geva L, Ashkenazi S, Kubler-Kielb J, Vinogradov E, Robbins JB, Schneerson R. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice. Vaccine. PMID 28797729 DOI: 10.1016/J.Vaccine.2017.07.070 |
0.589 |
|
| 2014 |
Robbins JB, Schneerson R, Kubler-Kielb J, Keith JM, Trollfors B, Vinogradov E, Shiloach J. Toward a new vaccine for pertussis. Proceedings of the National Academy of Sciences of the United States of America. 111: 3213-6. PMID 24556987 DOI: 10.1073/pnas.1324149111 |
0.657 |
|
| 2013 |
Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine. 31: 5178-91. PMID 23994021 DOI: 10.1016/j.vaccine.2013.08.034 |
0.623 |
|
| 2013 |
Keitel WA, Dai Z, Awe RW, Atmar RL, Morris S, Schneerson R, Robbins JB. Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen. Bmc Infectious Diseases. 13: 276. PMID 23783070 DOI: 10.1186/1471-2334-13-276 |
0.578 |
|
| 2013 |
Szu SC, Hunt S, Xie G, Robbins JB, Schneerson R, Gupta RK, Zhao Z, Tan X. A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned. Vaccine. 31: 1970-4. PMID 23422143 DOI: 10.1016/j.vaccine.2013.02.006 |
0.657 |
|
| 2012 |
Pozsgay V, Kubler-Kielb J, Coxon B, Santacroce P, Robbins JB, Schneerson R. Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigens. The Journal of Organic Chemistry. 77: 5922-41. PMID 22713129 DOI: 10.1021/jo300299p |
0.802 |
|
| 2012 |
Schmidt DS, Bieging KT, Gomez-de-León P, Villaseñor-Sierra A, Inostroza J, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S. Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera. The Pediatric Infectious Disease Journal. 31: 876-8. PMID 22549435 DOI: 10.1097/INF.0b013e31825ab166 |
0.584 |
|
| 2012 |
Bellanti JA, Lin FY, Chu C, Shiloach J, Leppla SH, Benavides GA, Karpas A, Moayeri M, Guo C, Robbins JB, Schneerson R. Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis. Clinical and Vaccine Immunology : Cvi. 19: 140-5. PMID 22190398 DOI: 10.1128/CVI.05556-11 |
0.616 |
|
| 2011 |
Robbins JB, Schneerson R, Xie G, Hanson LÃ…, Ã…ke-Hanson L, Miller MA. Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. Proceedings of the National Academy of Sciences of the United States of America. 108: 17871-5. PMID 22025709 DOI: 10.1073/pnas.1114489108 |
0.62 |
|
| 2011 |
Gottfredsson M, Reynisson IK, Ingvarsson RF, Kristjansdottir H, Nardini MV, Sigurdsson JF, Schneerson R, Robbins JB, Miller MA. Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: e117-24. PMID 21946191 DOI: 10.1093/cid/cir500 |
0.557 |
|
| 2011 |
Pozsgay V, Kubler-Kielb J, Coxon B, Marques A, Robbins JB, Schneerson R. Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease. Carbohydrate Research. 346: 1551-63. PMID 21601180 DOI: 10.1016/j.carres.2011.04.045 |
0.831 |
|
| 2011 |
Lin FY, Weisman LE, Azimi P, Young AE, Chang K, Cielo M, Moyer P, Troendle JF, Schneerson R, Robbins JB. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease. The Pediatric Infectious Disease Journal. 30: 759-63. PMID 21540758 DOI: 10.1097/INF.0b013e31821dc76f |
0.485 |
|
| 2011 |
Ren D, Yu S, Gao S, Peng D, Petralia RS, Muszynski A, Carlson RW, Robbins JB, Tsai CM, Lim DJ, Gu XX. Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis. Vaccine. 29: 4210-7. PMID 21501641 DOI: 10.1016/j.vaccine.2011.03.102 |
0.409 |
|
| 2011 |
Thiem VD, Lin FY, Canh do G, Son NH, Anh DD, Mao ND, Chu C, Hunt SW, Robbins JB, Schneerson R, Szu SC. The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines. Clinical and Vaccine Immunology : Cvi. 18: 730-5. PMID 21411598 DOI: 10.1128/CVI.00532-10 |
0.615 |
|
| 2011 |
Kubler-Kielb J, Vinogradov E, Lagergård T, Ginzberg A, King JD, Preston A, Maskell DJ, Pozsgay V, Keith JM, Robbins JB, Schneerson R. Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine. Proceedings of the National Academy of Sciences of the United States of America. 108: 4087-92. PMID 21367691 DOI: 10.1073/Pnas.1100782108 |
0.841 |
|
| 2011 |
Rouphael NG, Satola S, Farley MM, Rudolph K, Schmidt DS, Gomez-de-León P, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S. Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a. Clinical and Vaccine Immunology : Cvi. 18: 243-7. PMID 21177919 DOI: 10.1128/CVI.00219-10 |
0.583 |
|
| 2010 |
Kubler-Kielb J, Vinogradov E, Mocca C, Pozsgay V, Coxon B, Robbins JB, Schneerson R. Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates. Carbohydrate Research. 345: 1600-8. PMID 20542498 DOI: 10.1016/j.carres.2010.05.006 |
0.822 |
|
| 2010 |
Kubler-Kielb J, Majadly F, Biesova Z, Mocca CP, Guo C, Nussenzweig R, Nussenzweig V, Mishra S, Wu Y, Miller LH, Keith JM, Liu TY, Robbins JB, Schneerson R. A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates. Proceedings of the National Academy of Sciences of the United States of America. 107: 1172-7. PMID 20080619 DOI: 10.1073/Pnas.0913374107 |
0.637 |
|
| 2010 |
Passwell JH, Ashkenzi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, Even-Nir H, Yerushalmi B, Chu C, Shiloach J, Robbins JB, Schneerson R. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. Vaccine. 28: 2231-5. PMID 20056180 DOI: 10.1016/j.vaccine.2009.12.050 |
0.586 |
|
| 2010 |
POZSGAY V, GLAUDEMANS CPJ, ROBBINS JB, SCHNEERSON R. ChemInform Abstract: Synthesis of a Tetrasaccharide Building Block of the O-Specific Polysaccharide of Shigella dysenteriae Type. Cheminform. 24: no-no. DOI: 10.1002/CHIN.199311268 |
0.539 |
|
| 2009 |
Biesova Z, Miller MA, Schneerson R, Shiloach J, Green KY, Robbins JB, Keith JM. Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine. 27: 6234-8. PMID 19686692 DOI: 10.1016/j.vaccine.2009.07.107 |
0.616 |
|
| 2009 |
Robbins JB, Kubler-Kielb J, Vinogradov E, Mocca C, Pozsgay V, Shiloach J, Schneerson R. Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates. Proceedings of the National Academy of Sciences of the United States of America. 106: 7974-8. PMID 19346477 DOI: 10.1073/pnas.0900891106 |
0.814 |
|
| 2009 |
Howitz MF, Simonsen J, Krause TG, Robbins JB, Schneerson R, Mølbak K, Miller MA. Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohort. The Pediatric Infectious Disease Journal. 28: 199-203. PMID 19165135 DOI: 10.1097/INF.0b013e31818c9049 |
0.527 |
|
| 2009 |
Robbins JB, Schneerson R, Keith JM, Miller MA, Kubler-Kielb J, Trollfors B. Pertussis vaccine: a critique. The Pediatric Infectious Disease Journal. 28: 237-41. PMID 19165133 DOI: 10.1097/INF.0b013e31818a8958 |
0.639 |
|
| 2009 |
Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von König CH, Han L, Hueston L, ... Robbins JB, et al. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine. 27: 803-14. PMID 19071179 DOI: 10.1016/J.Vaccine.2008.11.072 |
0.305 |
|
| 2009 |
Kubler-Kielb J, Vinogradov E, Mocca C, Guo C, Schneerson R, Robbins JB. Shigella sonnei oligosaccharide-protein conjugates Procedia in Vaccinology. 1: 63-66. DOI: 10.1016/J.PROVAC.2009.07.011 |
0.488 |
|
| 2008 |
Kubler-Kielb J, Vinogradov E, Hu H, Leppla SH, Robbins JB, Schneerson R. Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component. Proceedings of the National Academy of Sciences of the United States of America. 105: 8709-12. PMID 18562275 DOI: 10.1073/pnas.0803897105 |
0.628 |
|
| 2008 |
Kubler-Kielb J, Vinogradov E, Ben-Menachem G, Pozsgay V, Robbins JB, Schneerson R. Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates. Vaccine. 26: 3587-93. PMID 18539367 DOI: 10.1016/j.vaccine.2008.04.079 |
0.829 |
|
| 2008 |
Singer DE, Schneerson R, Bautista CT, Rubertone MV, Robbins JB, Taylor DN. Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel. Vaccine. 26: 869-73. PMID 18206278 DOI: 10.1016/j.vaccine.2007.11.085 |
0.632 |
|
| 2007 |
Howitz M, Krause TG, Simonsen JB, Hoffmann S, Frisch M, Nielsen NM, Robbins J, Schneerson R, Mølbak K, Miller MA. Lack of association between group B meningococcal disease and autoimmune disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 1327-34. PMID 17968829 DOI: 10.1086/522190 |
0.595 |
|
| 2007 |
Pozsgay V, Kubler-Kielb J, Schneerson R, Robbins JB. Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 14478-82. PMID 17726093 DOI: 10.1073/pnas.0706969104 |
0.822 |
|
| 2007 |
Jin Z, Romero-Steiner S, Carlone GM, Robbins JB, Schneerson R. Haemophilus influenzae type a infection and its prevention. Infection and Immunity. 75: 2650-4. PMID 17353280 DOI: 10.1128/IAI.01774-06 |
0.496 |
|
| 2007 |
Robbins JB, Schneerson R, Keith JM, Shiloach J, Miller M, Trollors B. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP. Vaccine. 25: 2811-6. PMID 17291636 DOI: 10.1016/j.vaccine.2006.12.013 |
0.603 |
|
| 2007 |
Chowers Y, Kirschner J, Keller N, Barshack I, Bar-Meir S, Ashkenazi S, Schneerson R, Robbins J, Passwell JH. O-specific [corrected] polysaccharide conjugate vaccine-induced [corrected] antibodies prevent invasion of Shigella into Caco-2 cells and may be curative. Proceedings of the National Academy of Sciences of the United States of America. 104: 2396-401. PMID 17287349 DOI: 10.1073/Pnas.0610833104 |
0.667 |
|
| 2007 |
Kubler-Kielb J, Majadly F, Wu Y, Narum DL, Guo C, Miller LH, Shiloach J, Robbins JB, Schneerson R. Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. Proceedings of the National Academy of Sciences of the United States of America. 104: 293-8. PMID 17190797 DOI: 10.1073/pnas.0609885104 |
0.638 |
|
| 2006 |
Kubler-Kielb J, Liu TY, Mocca C, Majadly F, Robbins JB, Schneerson R. Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugates. Infection and Immunity. 74: 4744-9. PMID 16861662 DOI: 10.1128/IAI.00315-06 |
0.588 |
|
| 2006 |
Fekete A, Hoogerhout P, Zomer G, Kubler-Kielb J, Schneerson R, Robbins JB, Pozsgay V. Synthesis of octa- and dodecamers of D-ribitol-1-phosphate and their protein conjugates. Carbohydrate Research. 341: 2037-48. PMID 16458277 DOI: 10.1016/j.carres.2005.10.023 |
0.802 |
|
| 2006 |
Ahmed A, Li J, Shiloach Y, Robbins JB, Szu SC. Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children. The Journal of Infectious Diseases. 193: 515-21. PMID 16425130 DOI: 10.1086/499821 |
0.329 |
|
| 2006 |
Stein DM, Robbins J, Miller MA, Lin FY, Schneerson R. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? Vaccine. 24: 221-8. PMID 16125824 DOI: 10.1016/j.vaccine.2005.07.084 |
0.639 |
|
| 2005 |
Jin Z, Bohach GA, Shiloach J, Norris SE, Freedberg DI, Deobald C, Coxon B, Robbins JB, Schneerson R. Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice. Infection and Immunity. 73: 7887-93. PMID 16299279 DOI: 10.1128/Iai.73.12.7887-7893.2005 |
0.601 |
|
| 2005 |
Claesson BA, Trollfors B, Lagergård T, Knutsson N, Schneerson R, Robbins JB. Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine. The Pediatric Infectious Disease Journal. 24: 463-4. PMID 15876951 DOI: 10.1097/01.inf.0000160955.26151.71 |
0.663 |
|
| 2005 |
Robbins JB, Schneerson R, Gotschlich EC. Surveillance for bacterial meningitis by means of polymerase chain reaction. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 26-7. PMID 15614688 DOI: 10.1086/426448 |
0.527 |
|
| 2005 |
Robbins JB, Schneerson R, Trollfors B, Sato H, Sato Y, Rappuoli R, Keith JM. The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins. The Journal of Infectious Diseases. 191: 81-8. PMID 15593007 DOI: 10.1086/426454 |
0.642 |
|
| 2004 |
Robbins JB, Schneerson R. Future vaccine development at NICHD. Annals of the New York Academy of Sciences. 1038: 49-59. PMID 15838097 DOI: 10.1196/annals.1315.011 |
0.67 |
|
| 2004 |
Canh DG, Lin FY, Thiem VD, Trach DD, Trong ND, Mao ND, Hunt S, Schneerson R, Robbins JB, Chu C, Shiloach J, Bryla DA, Bonnet MC, Schulz D, Szu SC. Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children. Infection and Immunity. 72: 6586-8. PMID 15501790 DOI: 10.1128/IAI.72.11.6586-6588.2004 |
0.557 |
|
| 2004 |
Glatman-Freedman A, Casadevall A, Dai Z, Jacobs WR, Li A, Morris SL, Navoa JA, Piperdi S, Robbins JB, Schneerson R, Schwebach JR, Shapiro M. Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. Journal of Clinical Microbiology. 42: 3225-31. PMID 15243086 DOI: 10.1128/Jcm.42.7.3225-3231.2004 |
0.592 |
|
| 2004 |
Robbins JB, Schneerson R, Horwith G, Naso R, Fattom A. Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines. American Heart Journal. 147: 593-8. PMID 15077073 DOI: 10.1016/j.ahj.2004.01.012 |
0.612 |
|
| 2003 |
Robbins JB, Schneerson R, Gotschlich EC, Mohammed I, Nasidi A, Chippaux JP, Bernardino L, Maiga MA. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Bulletin of the World Health Organization. 81: 745-50; discussion 7. PMID 14758435 DOI: 10.1590/S0042-96862003001000010 |
0.607 |
|
| 2003 |
Mai NL, Phan VB, Vo AH, Tran CT, Lin FY, Bryla DA, Chu C, Schiloach J, Robbins JB, Schneerson R, Szu SC. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. The New England Journal of Medicine. 349: 1390-1. PMID 14523155 DOI: 10.1056/NEJM200310023491423 |
0.593 |
|
| 2003 |
Jin Z, Chu C, Robbins JB, Schneerson R. Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice. Infection and Immunity. 71: 5115-20. PMID 12933854 DOI: 10.1128/IAI.71.9.5115-5120.2003 |
0.619 |
|
| 2003 |
Passwell JH, Ashkenazi S, Harlev E, Miron D, Ramon R, Farzam N, Lerner-Geva L, Levi Y, Chu C, Shiloach J, Robbins JB, Schneerson R. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children. The Pediatric Infectious Disease Journal. 22: 701-6. PMID 12913770 DOI: 10.1097/01.Inf.0000078156.03697.A5 |
0.599 |
|
| 2003 |
Schneerson R, Kubler-Kielb J, Liu TY, Dai ZD, Leppla SH, Yergey A, Backlund P, Shiloach J, Majadly F, Robbins JB. Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proceedings of the National Academy of Sciences of the United States of America. 100: 8945-50. PMID 12857944 DOI: 10.1073/pnas.1633512100 |
0.626 |
|
| 2003 |
Gu XX, Rudy SF, Chu C, McCullagh L, Kim HN, Chen J, Li J, Robbins JB, Van Waes C, Battey JF. Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae. Vaccine. 21: 2107-14. PMID 12706701 DOI: 10.1016/S0264-410X(02)00768-5 |
0.315 |
|
| 2003 |
Navoa JA, Laal S, Pirofski LA, McLean GR, Dai Z, Robbins JB, Schneerson R, Casadevall A, Glatman-Freedman A. Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clinical and Diagnostic Laboratory Immunology. 10: 88-94. PMID 12522045 DOI: 10.1128/Cdli.10.1.88-94.2003 |
0.574 |
|
| 2003 |
Pozsgay V, Coxon B, Glaudemans CPJ, Schneerson R, Robbins JB. Towards an Oligosaccharide-Based Glycoconjugate Vaccine Against Shigella dysenteriae Type 1 Cheminform. 34. DOI: 10.1002/CHIN.200329260 |
0.61 |
|
| 2002 |
Robbins JB, Schneerson R, Trollfors B. Pertussis in developed countries. Lancet (London, England). 360: 657-8. PMID 12241870 DOI: 10.1016/S0140-6736(02)09882-3 |
0.451 |
|
| 2002 |
Leppla SH, Robbins JB, Schneerson R, Shiloach J. Development of an improved vaccine for anthrax. The Journal of Clinical Investigation. 110: 141-4. PMID 12122102 DOI: 10.1172/JCI16204 |
0.596 |
|
| 2002 |
Schwebach JR, Glatman-Freedman A, Gunther-Cummins L, Dai Z, Robbins JB, Schneerson R, Casadevall A. Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo. Infection and Immunity. 70: 2566-75. PMID 11953397 DOI: 10.1128/IAI.70.5.2566-2575.2002 |
0.515 |
|
| 2002 |
Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. The New England Journal of Medicine. 346: 491-6. PMID 11844850 DOI: 10.1056/NEJMoa011297 |
0.581 |
|
| 2001 |
Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Pediatrics. 108: E115. PMID 11731642 DOI: 10.1542/PEDS.108.6.E115 |
0.665 |
|
| 2001 |
Taranger J, Trollfors B, Bergfors E, Knutsson N, Sundh V, Lagergård T, Lind-Brandberg L, Zackrisson G, White J, Cicirello H, Fusco J, Robbins JB. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 33: 1004-10. PMID 11528572 DOI: 10.1086/322639 |
0.312 |
|
| 2001 |
Trollfors B, Lagergård T, Taranger J, Bergfors E, Schneerson R, Robbins JB. Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis. Clinical and Diagnostic Laboratory Immunology. 8: 1015-7. PMID 11527820 DOI: 10.1128/CDLI.8.5.1015-1017.2001 |
0.579 |
|
| 2001 |
Schwebach JR, Casadevall A, Schneerson R, Dai Z, Wang X, Robbins JB, Glatman-Freedman A. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infection and Immunity. 69: 5671-8. PMID 11500443 DOI: 10.1128/Iai.69.9.5671-5678.2001 |
0.532 |
|
| 2001 |
Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, Kossaczka Z, Bryla DA, Shiloach J, Robbins JB, Schneerson R, Szu SC. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. The New England Journal of Medicine. 344: 1263-9. PMID 11320385 DOI: 10.1056/NEJM200104263441701 |
0.594 |
|
| 2001 |
Passwell JH, Harlev E, Ashkenazi S, Chu C, Miron D, Ramon R, Farzan N, Shiloach J, Bryla DA, Majadly F, Roberson R, Robbins JB, Schneerson R. Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel. Infection and Immunity. 69: 1351-7. PMID 11179298 DOI: 10.1128/Iai.69.3.1351-1357.2001 |
0.647 |
|
| 2000 |
Robbins JB, Schneerson R, Gotschlich EC. A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine. The Pediatric Infectious Disease Journal. 19: 945-53. PMID 11055594 DOI: 10.1097/00006454-200010000-00001 |
0.617 |
|
| 2000 |
Kossaczka Z, Shiloach J, Johnson V, Taylor DN, Finkelstein RA, Robbins JB, Szu SC. Vibrio cholerae O139 conjugate vaccines: Synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice Infection and Immunity. 68: 5037-5043. PMID 10948122 DOI: 10.1128/IAI.68.9.5037-5043.2000 |
0.391 |
|
| 2000 |
Pavliakova D, Moncrief JS, Lyerly DM, Schiffman G, Bryla DA, Robbins JB, Schneerson R. Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: Studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice Infection and Immunity. 68: 2161-2166. PMID 10722615 DOI: 10.1128/IAI.68.4.2161-2166.2000 |
0.619 |
|
| 2000 |
Taranger J, Trollfors B, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. The Journal of Infectious Diseases. 181: 1010-3. PMID 10720524 DOI: 10.1086/315318 |
0.624 |
|
| 2000 |
Konadu EY, Lin FY, Hó VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas AB, Li J, Bryla DA, Robbins JB, Szu SC. Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infection and Immunity. 68: 1529-34. PMID 10678970 DOI: 10.1128/IAI.68.3.1529-1534.2000 |
0.324 |
|
| 2000 |
Sun J, Chen J, Cheng Z, Robbins JB, Battey JF, Gu XX. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model. Vaccine. 18: 1264-72. PMID 10649628 DOI: 10.1016/S0264-410X(99)00381-3 |
0.409 |
|
| 2000 |
Taranger J, Trollfors B, Lagergârd T, Robbins JB. Protection against pertussis with a monocomponent pertussis toxoid vaccine. Biologicals : Journal of the International Association of Biological Standardization. 27: 89. PMID 10600190 DOI: 10.1006/BIOL.1999.0186 |
0.342 |
|
| 1999 |
Konadu E, Donohue-Rolfe A, Calderwood SB, Pozsgay V, Shiloach J, Robbins JB, Szu SC. Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice. Infection and Immunity. 67: 6191-3. PMID 10531288 DOI: 10.1128/IAI.67.11.6191-6193.1999 |
0.381 |
|
| 1999 |
Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infection and Immunity. 67: 5806-10. PMID 10531232 DOI: 10.1128/IAI.67.11.5806-5810.1999 |
0.603 |
|
| 1999 |
Pavliakova D, Chu C, Bystricky S, Tolson NW, Shiloach J, Kaufman JB, Bryla DA, Robbins JB, Schneerson R. Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice. Infection and Immunity. 67: 5526-9. PMID 10496944 DOI: 10.1128/IAI.67.10.5526-5529.1999 |
0.62 |
|
| 1999 |
Robbins JB. Pertussis in adults: Introduction Clinical Infectious Diseases. 28. PMID 10447024 DOI: 10.1086/515054 |
0.343 |
|
| 1999 |
Pozsgay V, Chu C, Pannell L, Wolfe J, Robbins JB, Schneerson R. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1 Proceedings of the National Academy of Sciences of the United States of America. 96: 5194-5197. PMID 10220442 DOI: 10.1073/PNAS.96.9.5194 |
0.649 |
|
| 1999 |
Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 28: 552-9. PMID 10194077 DOI: 10.1086/515172 |
0.602 |
|
| 1998 |
Gupta RK, Taylor DN, Bryla DA, Robbins JB, Szu SC. Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers Infection and Immunity. 66: 3095-3099. PMID 9632571 DOI: 10.1128/IAI.66.7.3095-3099.1998 |
0.399 |
|
| 1998 |
Gu XX, Chen J, Barenkamp SJ, Robbins JB, Tsai CM, Lim DJ, Battey J. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infection and Immunity. 66: 1891-7. PMID 9573066 DOI: 10.1128/IAI.66.5.1891-1897.1998 |
0.381 |
|
| 1998 |
Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Immunization of children with pertussis toxoid decreases spread of pertussis within the family. The Pediatric Infectious Disease Journal. 17: 196-9. PMID 9535245 DOI: 10.1097/00006454-199803000-00005 |
0.588 |
|
| 1998 |
Konadu EY, Parke JC, Tran HT, Bryla DA, Robbins JB, Szu SC. Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults. The Journal of Infectious Diseases. 177: 383-7. PMID 9466525 DOI: 10.1086/514203 |
0.457 |
|
| 1997 |
Gu XX, Sun J, Jin S, Barenkamp SJ, Lim DJ, Robbins JB, Battey J. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas. Infection and Immunity. 65: 4488-93. PMID 9353024 DOI: 10.1128/IAI.65.11.4488-4493.1997 |
0.414 |
|
| 1997 |
Robbins JB, Towne DW, Gotschlich EC, Schneerson R. 'Love's labours lost': Failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa Lancet. 350: 880-882. PMID 9310615 DOI: 10.1016/S0140-6736(97)03227-3 |
0.624 |
|
| 1997 |
Kossaczka Z, Bystricky S, Bryla DA, Shiloach J, Robbins JB, Szu SC. Synthesis and immunological properties of Vi and Di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker Infection and Immunity. 65: 2088-2093. PMID 9169736 DOI: 10.1128/IAI.65.6.2088-2093.1997 |
0.381 |
|
| 1997 |
Cohen D, Ashkenazi S, Green MS, Gdalevich M, Robin G, Slepon R, Yavzori M, Orr N, Block C, Ashkenazi I, Shemer J, Taylor DN, Hale TL, Sadoff JC, Pavliakova D, ... ... Robbins JB, et al. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet (London, England). 349: 155-9. PMID 9111538 DOI: 10.1016/S0140-6736(96)06255-1 |
0.347 |
|
| 1997 |
Trollfors B, Taranger J, Lagergård T, Lind L, Sundh V, Zackrisson G, Bryla DA, Robbins JB. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis. The Journal of Pediatrics. 130: 532-6. PMID 9108848 DOI: 10.1016/S0022-3476(97)70234-8 |
0.338 |
|
| 1997 |
Taranger J, Trollfors B, Lagergård T, Lind L, Sundh V, Zackrisson G, Bryla DA, Robbins JB. Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants. The Pediatric Infectious Disease Journal. 16: 180-4. PMID 9041597 DOI: 10.1097/00006454-199702000-00003 |
0.303 |
|
| 1997 |
Passwell JH, Ashkenazi S, Robbins JB, Schneerson R. Safety and Immunogenicity of Experimental Shigella O-Specific Polysaccharide Conjugate Vaccines in Children • 754 Pediatric Research. 41: 128-128. DOI: 10.1203/00006450-199704001-00774 |
0.626 |
|
| 1997 |
Taranger J, Trollfors B, Lagergård T, Robbins JB. Protection against pertussis with a monocomponent pertussis toxoid vaccine International Journal of Infectious Diseases. 1: 148-151. DOI: 10.1016/S1201-9712(97)90078-3 |
0.322 |
|
| 1997 |
Schneerson R, Robbins JB, Taranger J, Trollfors B, Lagergård T. Toxoid vaccine for pertussis The Lancet. 349: 137-138. DOI: 10.1016/S0140-6736(05)60928-2 |
0.606 |
|
| 1996 |
Cohen D, Ashkenazi S, Green M, Lerman Y, Slepon R, Robin G, Orr N, Taylor DN, Sadoff JC, Chu C, Shiloach J, Schneerson R, Robbins JB. Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers. Infection and Immunity. 64: 4074-7. PMID 8926071 DOI: 10.1128/Iai.64.10.4074-4077.1996 |
0.642 |
|
| 1996 |
Gu XX, Tsai CM, Ueyama T, Barenkamp SJ, Robbins JB, Lim DJ. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infection and Immunity. 64: 4047-53. PMID 8926067 DOI: 10.1128/IAI.64.10.4047-4053.1996 |
0.417 |
|
| 1996 |
Schneerson R, Robbins JB, Taranger J, Lagergård T, Trollfors B. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned Lancet. 348: 1289-1292. PMID 8909384 DOI: 10.1016/S0140-6736(96)05243-9 |
0.607 |
|
| 1996 |
Schneerson R, Robbins JB. Ukraine's diphtheria campaign Lancet. 348: 1245. PMID 8898058 DOI: 10.1016/S0140-6736(05)65522-5 |
0.458 |
|
| 1996 |
Robbins JB, Schneerson R, Anderson P, Smith DH. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: Impact on public health and implications for other polysaccharide-based vaccines Journal of the American Medical Association. 276: 1181-1185. PMID 8827975 DOI: 10.1001/jama.276.14.1181 |
0.625 |
|
| 1996 |
Claesson BA, Trollfors B, Anderson PW, Johansson J, Taranger J, Schneerson R, Robbins JB. Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. The Pediatric Infectious Disease Journal. 15: 170-2. PMID 8822293 DOI: 10.1097/00006454-199602000-00016 |
0.654 |
|
| 1996 |
Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization Vaccine. 14: 435-438. PMID 8735556 DOI: 10.1016/0264-410X(95)00186-5 |
0.383 |
|
| 1996 |
Cohen D, Ashkenazi S, Green M, Gdalevich M, Yavzori M, Orr N, Robin G, Slepon R, Lerman Y, Block C, Ashkenazi I, Taylor D, Hale L, Sadoff J, Schneerson R, ... Robbins J, et al. Clinical trials of Shigella vaccines in Israel. Advances in Experimental Medicine and Biology. 397: 159-67. PMID 8718595 DOI: 10.1007/978-1-4899-1382-1_21 |
0.519 |
|
| 1996 |
Konadu E, Shiloach J, Bryla DA, Robbins JB, Szu SC. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid, with emphasis on the role of O acetyls Infection and Immunity. 64: 2709-2715. PMID 8698499 DOI: 10.1128/IAI.64.7.2709-2715.1996 |
0.365 |
|
| 1996 |
Dubois EP, Robbins JB, Pozsgay V. Chemical approaches to bacterial vaccines. Synthesis of mycobacterial oligosaccharide-protein conjugates for use as serodiagnostics and immunogens Bioorganic and Medicinal Chemistry Letters. 6: 1387-1392. DOI: 10.1016/0960-894X(96)00235-1 |
0.3 |
|
| 1995 |
Robbins JB, Schneerson R, Szu SC. Perspective: Hypothesis: Serum igg antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum Journal of Infectious Diseases. 171: 1387-1398. PMID 7769272 DOI: 10.1093/infdis/171.6.1387 |
0.645 |
|
| 1995 |
Trollfors B, Taranger J, Lagergård T, Lind L, Sundh V, Zackrisson G, Lowe CU, Blackwelder W, Robbins JB. A placebo-controlled trial of a pertussis-toxoid vaccine. The New England Journal of Medicine. 333: 1045-50. PMID 7675047 DOI: 10.1056/NEJM199510193331604 |
0.326 |
|
| 1995 |
Robbins JB, Schneerson R, Bennett JE. The Devi case and more. Science (New York, N.Y.). 269: 1031; author reply 1. PMID 7652539 DOI: 10.1126/science.7652540 |
0.422 |
|
| 1995 |
Liao J, Nickerson KG, Bystricky S, Robbins JB, Schneerson R, Szu SC, Kabat EA. Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhi. Infection and Immunity. 63: 4429-32. PMID 7591081 DOI: 10.1128/Iai.63.11.4429-4432.1995 |
0.652 |
|
| 1995 |
Gupta RK, Egan W, Bryla DA, Robbins JB, Szu SC. Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes Infection and Immunity. 63: 2805-2810. PMID 7542631 DOI: 10.1128/IAI.63.8.2805-2810.1995 |
0.314 |
|
| 1995 |
Szu SC, Gupta R, Kovac P, Taylor DN, Robbins JB. Development of O-specific polysaccharide-protein conjugates is based upon the protective effect of serum vibriocidal antibodies against cholera Bulletin De L'Institut Pasteur. 93: 269-272. DOI: 10.1016/0020-2452(96)85761-7 |
0.376 |
|
| 1994 |
Polotsky VY, Robbins JB, Bryla D, Schneerson R. Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid Infection and Immunity. 62: 210-214. PMID 8262629 DOI: 10.1128/IAI.62.1.210-214.1994 |
0.609 |
|
| 1994 |
Isacson J, Trollfors B, Taranger J, MacDowall I, Johansson J, Lagergård T, Robbins JB. Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. The Pediatric Infectious Disease Journal. 13: 22-7. PMID 8170728 DOI: 10.1097/00006454-199401000-00006 |
0.39 |
|
| 1994 |
Keitel WA, Bond NL, Zahradnik JM, Cramton TA, Robbins JB. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine. 12: 195-9. PMID 8165850 DOI: 10.1016/0264-410X(94)90194-5 |
0.339 |
|
| 1994 |
Avanzini MA, Björkander J, Söderström R, Söderström T, Schneerson R, Robbins JB, Hanson LA. Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections. Clinical and Experimental Immunology. 96: 54-8. PMID 8149666 DOI: 10.1111/J.1365-2249.1994.TB06229.X |
0.65 |
|
| 1994 |
Polotsky VY, Schneerson R, Bryla D, Robbins JB. Immunogenicity of two types of Shigella flexneri 2a O-specific polysaccharide-tetanus toxoid conjugates Annals of the New York Academy of Sciences. 730: 359-360. PMID 8080210 DOI: 10.1111/j.1749-6632.1994.tb44292.x |
0.561 |
|
| 1994 |
Szu SC, Bystricky S, Hinojosa-Ahumada M, Egan W, Robbins JB. Synthesis and some immunologic properties of an O-acetyl pectin [poly(1→4)-α-D-GalpA]-protein conjugate as a vaccine for typhoid fever Infection and Immunity. 62: 5545-5549. PMID 7960137 DOI: 10.1128/IAI.62.12.5545-5549.1994 |
0.392 |
|
| 1994 |
Konadu E, Robbins JB, Shiloach J, Bryla DA, Szu SC. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines Infection and Immunity. 62: 5048-5054. PMID 7927787 DOI: 10.1128/IAI.62.11.5048-5054.1994 |
0.396 |
|
| 1994 |
Szu SC, Taylor DN, Trofa AC, Clements JD, Shiloach J, Sadoff JC, Bryla DA, Robbins JB. Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines. Infection and Immunity. 62: 4440-4. PMID 7927707 DOI: 10.1128/IAI.62.10.4440-4444.1994 |
0.405 |
|
| 1993 |
ROBBINS JB, PITTMAN M, TROLLFORS B, LAGERGARD TA, TARANGER J, SCHNEERSON R. Primum non nocere The Pediatric Infectious Disease Journal. 12: 795-807. DOI: 10.1097/00006454-199310000-00001 |
0.432 |
|
| 1992 |
Fattom A, Shiloach J, Bryla D, Fitzgerald D, Pastan I, Karakawa WW, Robbins JB, Schneerson R. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate. Infection and Immunity. 60: 584-9. PMID 1730492 DOI: 10.1128/IAI.60.2.584-589.1992 |
0.605 |
|
| 1992 |
Gupta RK, Szu SC, Finkelstein RA, Robbins JB. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype inaba bound to cholera toxin Infection and Immunity. 60: 3201-3208. PMID 1639490 DOI: 10.1128/IAI.60.8.3201-3208.1992 |
0.362 |
|
| 1992 |
Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. The Journal of Infectious Diseases. 165: 1086-93. PMID 1583327 DOI: 10.1093/infdis/165.6.1086 |
0.617 |
|
| 1992 |
Schneerson R, Levi L, Robbins JB, Bryla DM, Schiffman G, Lagergard T. Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin Infection and Immunity. 60: 3528-3532. PMID 1500160 DOI: 10.1128/IAI.60.9.3528-3532.1992 |
0.623 |
|
| 1992 |
Watson DC, Robbins JB, Szu SC. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine Infection and Immunity. 60: 4679-4686. PMID 1383154 DOI: 10.1128/IAI.60.11.4679-4686.1992 |
0.421 |
|
| 1992 |
Robbins JB, Chu C, Schneerson R. Hypothesis for vaccine development: Protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum igg antibodies to the o-specific polysaccharide of their lipopolysaccharides Clinical Infectious Diseases. 15: 346-361. PMID 1381621 DOI: 10.1093/clinids/15.2.346 |
0.667 |
|
| 1992 |
Poszgay V, Glaudemans CPJ, Robbins JB, Schneerson R. A synthetic octasaccharide mimics the native, O-specific determinant of the Shigella dysenteriae type 1 lipopolysaccharide Bioorganic and Medicinal Chemistry Letters. 2: 255-260. DOI: 10.1016/S0960-894X(01)81075-1 |
0.545 |
|
| 1992 |
Pozsgay V, Glaudemans CPJ, Robbins JB, Schneerson R. Synthesis of a tetrasaccharide building block of the O-specific polysaccharide of Shigella dysenteriae type 1 Tetrahedron. 48: 10249-10264. DOI: 10.1016/S0040-4020(01)88331-9 |
0.541 |
|
| 1992 |
Gupta RK, Robbins JB, Szu SC. Preparation and characterization of detoxified lipopolysaccharide-cholera toxin conjugate vaccine for cholera Vaccine. 10: 269. DOI: 10.1016/0264-410X(92)90192-M |
0.365 |
|
| 1991 |
Robbins JB, Chu C, Watson DC, Szu SC, Daniels EM, Lowe CU, Schneerson R. O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseases. Reviews of Infectious Diseases. S362-5. PMID 2047664 DOI: 10.1093/CLINIDS/13.SUPPLEMENT_4.S362 |
0.654 |
|
| 1991 |
Szu SC, Li XR, Stone AL, Robbins JB. Relation between structure and immunologic properties of the Vi capsular polysaccharide Infection and Immunity. 59: 4555-4561. PMID 1937814 DOI: 10.1128/IAI.59.12.4555-4561.1991 |
0.301 |
|
| 1991 |
Chu CY, Liu BK, Watson D, Szu SS, Bryla D, Shiloach J, Schneerson R, Robbins JB. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infection and Immunity. 59: 4450-8. PMID 1937803 DOI: 10.1128/IAI.59.12.4450-4458.1991 |
0.658 |
|
| 1991 |
Devi SJN, Robbins JB, Schneerson R. Antibodies to poly[(2→8)-α-N-acetylneuraminic acid] and poly[(2→9)-α-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: Potential vaccines for groups B and C meningococci and E. coli K1 Proceedings of the National Academy of Sciences of the United States of America. 88: 7175-7179. PMID 1908091 DOI: 10.1073/PNAS.88.16.7175 |
0.577 |
|
| 1991 |
Devi SJN, Schneerson R, Egan W, Vann WF, Robbins JB, Schiloach J. Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated) Infection and Immunity. 59: 732-736. PMID 1898915 DOI: 10.1128/IAI.59.2.732-736.1991 |
0.558 |
|
| 1991 |
Claesson BA, Schneerson R, Lagergård T, Trollfors B, Taranger J, Johansson J, Bryla D, Robbins JB. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. The Pediatric Infectious Disease Journal. 10: 560-4. PMID 1891286 DOI: 10.1097/00006454-199108000-00002 |
0.656 |
|
| 1991 |
Devi SJ, Schneerson R, Egan W, Ulrich TJ, Bryla D, Robbins JB, Bennett JE. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infection and Immunity. 59: 3700-7. PMID 1716613 DOI: 10.1128/IAI.59.10.3700-3707.1991 |
0.685 |
|
| 1990 |
Lagergard T, Shiloach J, Robbins JB, Schneerson R. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid Infection and Immunity. 58: 687-694. PMID 2407652 DOI: 10.1128/IAI.58.3.687-694.1990 |
0.605 |
|
| 1990 |
Lue C, Prince SJ, Fattom A, Schneerson R, Robbins JB, Mestecky J. Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoid. Infection and Immunity. 58: 2547-54. PMID 2370107 DOI: 10.1128/IAI.58.8.2547-2554.1990 |
0.633 |
|
| 1990 |
Fattom A, Lue C, Szu SC, Mestecky J, Schiffman G, Bryla D, Vann WF, Watson D, Kimzey LM, Robbins JB. Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid. Infection and Immunity. 58: 2309-12. PMID 2365462 DOI: 10.1128/IAI.58.7.2309-2312.1990 |
0.34 |
|
| 1990 |
Claesson BA, Schneerson R, Trollfors B, Lagergrd T, Taranger J, Robbins JB. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children The Journal of Pediatrics. 116: 929-931. PMID 2348298 DOI: 10.1016/S0022-3476(05)80655-9 |
0.605 |
|
| 1990 |
Sarnaik S, Kaplan J, Schiffman G, Bryla D, Robbins JB, Schneerson R. Studies on Pneumococcus vaccine alone or mixed with DTP and on pneumococcus type 6B and haemophilis influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two-to five-year-old children with sickle cell anemia Pediatric Infectious Disease Journal. 9: 181-186. PMID 2336298 DOI: 10.1097/00006454-199003000-00007 |
0.627 |
|
| 1990 |
Krantz I, Sekura R, Trollfors B, Taranger J, Zackrisson G, Lagergård T, Schneerson R, Robbins J. Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children. The Journal of Pediatrics. 116: 539-43. PMID 2319400 DOI: 10.1016/S0022-3476(05)81599-9 |
0.625 |
|
| 1990 |
Robbins JB, Schneerson R. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D New England Journal of Medicine. 323: 1415-1416. PMID 2233910 DOI: 10.1056/NEJM199011153232010 |
0.604 |
|
| 1990 |
Fattom A, Schneerson R, Szu SC, Vann WF, Shiloach J, Karakawa WW, Robbins JB. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infection and Immunity. 58: 2367-74. PMID 2114365 DOI: 10.1128/IAI.58.7.2367-2374.1990 |
0.623 |
|
| 1989 |
Szu SC, Li X, Schneerson R, Vickers JH, Bryla D, Robbins JB. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi Infection and Immunity. 57: 3823-3827. PMID 2807549 DOI: 10.1128/iai.57.12.3823-3827.1989 |
0.556 |
|
| 1989 |
Claesson BA, Schneerson R, Robbins JB, Johansson J, Lagergard T, Taranger J, Bryla D, Levi L, Cramton T, Trollfors B. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. The Journal of Pediatrics. 114: 97-100. PMID 2783345 DOI: 10.1016/S0022-3476(89)80611-0 |
0.602 |
|
| 1989 |
Robbins JB, Schneerson R, Szu SC, Fattom A, Yang Y, Lagergard T, Chu C, Sørensen US. Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates. Current Topics in Microbiology and Immunology. 146: 169-80. PMID 2659266 DOI: 10.1007/978-3-642-74529-4_18 |
0.616 |
|
| 1989 |
Daniels EM, Schneerson R, Egan WM, Szu SC, Robbins JB. Characterization of the Salmonella paratyphi C Vi polysaccharide Infection and Immunity. 57: 3159-3164. PMID 2506132 DOI: 10.1128/iai.57.10.3159-3164.1989 |
0.533 |
|
| 1988 |
Fattom A, Vann WF, Szu SC, Sutton A, Li X, Bryla D, Schiffman G, Robbins JB, Schneerson R. Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates. Infection and Immunity. 56: 2292-8. PMID 3410538 DOI: 10.1128/iai.56.9.2292-2298.1988 |
0.564 |
|
| 1988 |
Claesson BA, Trollfors B, Lagergard T, Taranger J, Bryla D, Otterman G, Cramton T, Yang Y, Reimer CB, Robbins JB. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. The Journal of Pediatrics. 112: 695-702. PMID 3361379 DOI: 10.1016/S0022-3476(88)80684-X |
0.435 |
|
| 1988 |
Tsui FP, Egan W, Summers MF, Byrd RA, Schneerson R, Robbins JB. Determination of the structure of the Escherichia coli K100 capsular polysaccharide, cross-reactive with the capsule from type b Haemophilus influenzae. Carbohydrate Research. 173: 65-74. PMID 3281753 DOI: 10.1016/S0008-6215(00)90803-6 |
0.522 |
|
| 1988 |
Lagergard T, Trollfors B, Claesson BA, Schneerson R, Robbins JB. Comparison between radioimmunoassay and direct and indirect enzyme-linked immunosorbent assays for determination of antibodies against Haemophilus influenzae type b capsular polysaccharide Journal of Clinical Microbiology. 26: 2554-2557. PMID 3230133 DOI: 10.1128/jcm.26.12.2554-2557.1988 |
0.602 |
|
| 1988 |
Tacket CO, Levine MM, Robbins JB. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever Vaccine. 6: 307-308. PMID 3188615 DOI: 10.1016/0264-410X(88)90175-2 |
0.409 |
|
| 1988 |
Bax A, Summers MF, Egan W, Guirgis N, Schneerson R, Robbins JB, Orskov F, Orskov I, Vann WF. Structural studies of the Escherichia coli K93 and K53 capsular polysaccharides. Carbohydrate Research. 173: 53-64. PMID 3128402 DOI: 10.1016/S0008-6215(00)90802-4 |
0.496 |
|
| 1987 |
Szu SC, Stone AL, Robbins JD, Schneerson R, Robbins JB. Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization and immunogenicity in laboratory animals Journal of Experimental Medicine. 166: 1510-1524. PMID 3681191 DOI: 10.1084/jem.166.5.1510 |
0.56 |
|
| 1987 |
Robbins JB, Schneerson R. Haemophilus influenzae type b: The search for a vaccine Pediatric Infectious Disease Journal. 6: 791-794. PMID 3313243 DOI: 10.1097/00006454-198708000-00039 |
0.674 |
|
| 1987 |
Losonsky GA, Luddy RE, Schwarz AD, Robbins JB. EVALUATION OF THE NEED TO IMMUNIZE CHILDREN WITH SICKLE CELL DISEASE WITH HEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINE Pediatric Research. 21: 301A-301A. DOI: 10.1203/00006450-198704010-00804 |
0.331 |
|
| 1986 |
Szu SC, Zon G, Schneerson R, Robbins JB. Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process Carbohydrate Research. 152: 7-20. PMID 3768916 DOI: 10.1016/S0008-6215(00)90283-0 |
0.521 |
|
| 1986 |
Schneerson R, Robbins JB, Parke JC, Bell C, Schlesselman JJ, Sutton A, Wang Z, Schiffman G, Karpas A, Shiloach J. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infection and Immunity. 52: 519-28. PMID 3516876 DOI: 10.1128/iai.52.2.519-528.1986 |
0.637 |
|
| 1986 |
Szu SC, Schneerson R, Robbins JB. Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci Infection and Immunity. 54. PMID 3095243 DOI: 10.1128/iai.54.2.448-455.1986 |
0.596 |
|
| 1986 |
Kabat EA, Nickerson KG, Liao J, Grossbard L, Osserman EF, Glickman E, Chess L, Robbins JB, Schneerson R, Yang YH. A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA. The Journal of Experimental Medicine. 164: 642-54. PMID 3088209 DOI: 10.1084/Jem.164.2.642 |
0.564 |
|
| 1986 |
Tacket CO, Ferreccio C, Robbins JB, Tsai CM, Schulz D, Cadoz M, Goudeau A, Levine MM. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. The Journal of Infectious Diseases. 154: 342-5. PMID 2425009 DOI: 10.1093/infdis/154.2.342 |
0.324 |
|
| 1985 |
Guirguis N, Schneerson R, Bax A, Egan W, Robbins JB, Shiloach J, Orskov I, Orskov F, el Kholy A. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies. The Journal of Experimental Medicine. 162: 1837-51. PMID 3934317 DOI: 10.1084/jem.162.6.1837 |
0.503 |
|
| 1985 |
Karakawa WW, Fournier JM, Vann WF, Arbeit R, Schneerson RS, Robbins JB. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. Journal of Clinical Microbiology. 22: 445-7. PMID 3930565 DOI: 10.1128/jcm.22.3.445-447.1985 |
0.504 |
|
| 1984 |
Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, Mäkelä PH, Broome CV, Facklam RR, Tiesjema RH. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. The Journal of Infectious Diseases. 148: 1136-59. PMID 6361173 DOI: 10.1093/infdis/148.6.1136 |
0.338 |
|
| 1984 |
Schneerson R, Robbins JB, Chu C, Sutton A, Vann W, Vickers JC, London WT, Curfman B, Hardegree MC, Shiloach J. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. Infection and Immunity. 45: 582-91. PMID 6332076 DOI: 10.1128/iai.45.3.582-591.1984 |
0.601 |
|
| 1984 |
Robbins JD, Robbins JB. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi Journal of Infectious Diseases. 150: 436-449. PMID 6207249 DOI: 10.1093/infdis/150.3.436 |
0.418 |
|
| 1983 |
Pozsgay V, Glaudemans CPJ, Robbins JB, Schneerson R. Synthesis of a tetrasaccharide donor corresponding to the O-specific polysaccharide of Shigella dysenteriae type 1 Carbohydrate Research. 244: 259-273. PMID 8348552 DOI: 10.1016/0008-6215(83)85006-X |
0.527 |
|
| 1983 |
Szu SC, Clarke S, Robbins JB. Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: Specificity of the phosphocholine binding and relation to several types Infection and Immunity. 39: 993-999. PMID 6832828 DOI: 10.1128/iai.39.2.993-999.1983 |
0.321 |
|
| 1983 |
Chu C, Schneerson R, Robbins JB, Rastogi SC. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates Infection and Immunity. 40: 245-256. PMID 6601061 DOI: 10.1128/iai.40.1.245-256.1983 |
0.633 |
|
| 1982 |
Penn RL, Lewin EB, Douglas RG, Schiffman G, Lee CJ, Robbins JB. Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination. Infection and Immunity. 36: 1261-2. PMID 7095850 DOI: 10.1128/iai.36.3.1261-1262.1982 |
0.339 |
|
| 1982 |
Sutton A, Schneerson R, Kendall-Morris S, Robbins JB. Differential complement resistance mediates virulence of Haemophilus influenzae tybe b Infection and Immunity. 35: 95-104. PMID 6976328 DOI: 10.1128/iai.35.1.95-104.1982 |
0.557 |
|
| 1982 |
Allen PZ, Glode M, Schneerson R, Robbins JB. Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum Journal of Clinical Microbiology. 15: 324-329. PMID 6802867 DOI: 10.1128/jcm.15.2.324-329.1982 |
0.621 |
|
| 1982 |
Patkowski A, Bujalowski W, Chu B, Schneerson R, Robbins JB. Light‐scattering spectroscopic study of polysaccharide protein conjugate Biopolymers. 21: 1503-1520. DOI: 10.1002/bip.360210804 |
0.498 |
|
| 1981 |
Steinhoff MC, Lewin EB, Gotschlich EC, Robbins JB. Group C Neisseria meningitidis variant polysaccharide vaccines in children. Infection and Immunity. 34: 144-6. PMID 6795122 DOI: 10.1128/Iai.34.1.144-146.1981 |
0.415 |
|
| 1980 |
Lee CJ, Pearson SJ, Robbins JB. Quantitative determination of pneumococcal capsular polysaccharides in the polyvalent vaccine. I. Standardization of an immunoelectrophoretic method. Journal of Biological Standardization. 8: 271-80. PMID 7204414 DOI: 10.1016/S0092-1157(80)80004-7 |
0.314 |
|
| 1979 |
Orskov F, Orskov I, Sutton A, Schneerson R, Lin W, Egan W, Hoff GE, Robbins JB. Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. The Journal of Experimental Medicine. 149: 669-85. PMID 372481 DOI: 10.1084/jem.149.3.669 |
0.58 |
|
| 1979 |
Glode MP, Lewin EB, Sutton A, Le CT, Gotschlich EC, Robbins JB. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. The Journal of Infectious Diseases. 139: 52-9. PMID 108338 DOI: 10.1093/Infdis/139.1.52 |
0.399 |
|
| 1978 |
Ginsburg CM, McCracken GH, Schneerson R, Robbins JB, Parke JC. Association between cross-reacting Escherichia coli K100 and disease caused by Haemophilus influenzae type b Infection and Immunity. 22: 339-342. PMID 365755 DOI: 10.1128/iai.22.2.339-342.1978 |
0.554 |
|
| 1977 |
Parke JC, Schneerson R, Robbins JB, Schlesselman JJ. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974 March 1976) Journal of Infectious Diseases. 136. PMID 408433 DOI: 10.1093/infdis/136.Supplement.S51 |
0.651 |
|
| 1977 |
Wong KH, Barrera O, Sutton A, May J, Hochstein DH, Robbins JD, Robbins JB, Parkman PD, Seligmann EB. Standardization and control of meningococcal vaccines, group A and group C polysaccharides Journal of Biological Standardization. 5: 197-215. PMID 408354 DOI: 10.1016/S0092-1157(77)80005-X |
0.323 |
|
| 1977 |
Robbins JB. Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency British Journal of Venereal Diseases. 53: 170-172. PMID 406011 DOI: 10.1136/sti.53.3.170 |
0.338 |
|
| 1976 |
Glode MP, Schiffer MS, Robbins JB, Khan W, Battle U, Armenta E. An outbreak of Hemophilus influenzae type b meningitis in an enclosed hospital population The Journal of Pediatrics. 88: 36-40. PMID 1082018 DOI: 10.1016/S0022-3476(76)80723-8 |
0.303 |
|
| 1975 |
Robbins JB, Schneerson R, Glode MP, Vann W, Schiffer MS, Liu TY, Parke JC, Huntley C. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. The Journal of Allergy and Clinical Immunology. 56: 141-51. PMID 239050 DOI: 10.1016/0091-6749(75)90119-0 |
0.531 |
|
| 1975 |
Schneerson R, Robbins JB. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5 New England Journal of Medicine. 292: 1093-1096. PMID 48191 DOI: 10.1056/NEJM197505222922103 |
0.613 |
|
| 1974 |
Smith DH, Robbins JB. Prevention of haemophilus influenzae type b disease in humans Preventive Medicine. 3: 446-448. PMID 4548185 DOI: 10.1016/0091-7435(74)90005-X |
0.354 |
|
| 1974 |
Aaron L, Handzel Z, Argaman M, Schneerson R, Robbins JB. Monospecific serum for typing Haemophilus influenzae type b produced by immunization with Escherichia coli strain 'Easter' Journal of Biological Standardization. 2. PMID 4213257 DOI: 10.1016/S0092-1157(74)80005-3 |
0.563 |
|
| 1974 |
Schiffer MS, MacLowry J, Schneerson R, Robbins JB, McReynolds JW, Thomas WJ, Bailey DW, Clarke EJ, Mueller EJ, Escamilla J. Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B. Lancet (London, England). 2: 257-9. PMID 4136145 DOI: 10.1016/S0140-6736(74)91416-0 |
0.501 |
|
| 1973 |
Myerowitz RL, Handzel ZT, Scheerson R, Robbins JB. Induction of Haemophilus influenzae type b capsular antibody in neonatal rabbits by gastrointestinal colonization with cross-reacting Escherichia coli Infection and Immunity. 7: 137-140. PMID 4572607 DOI: 10.1128/iai.7.2.137-140.1973 |
0.32 |
|
| 1973 |
Robbins JB, Parke JC, Schneerson R, Whisnant JK. Quantitative measurement of “natural” and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies Pediatric Research. 7: 103-110. PMID 4120458 DOI: 10.1203/00006450-197303000-00001 |
0.616 |
|
| 1972 |
Parke JC, Schneerson R, Robbins JB. The attack rate, age incidence, racial distribution, and case fatality rate of Hemophilus influenzae type b meningitis in Mecklenburg County, North Carolina The Journal of Pediatrics. 81: 765-769. PMID 5074353 DOI: 10.1016/S0022-3476(72)80099-4 |
0.5 |
|
| 1972 |
Robbins JB, Myerowitz L, Whisnant JK, Argaman M, Schneerson R, Handzel ZT, Gotschlich EC. Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3 Infection and Immunity. 6: 651-656. PMID 4118016 DOI: 10.1128/Iai.6.5.651-656.1972 |
0.57 |
|
| 1972 |
Myerowitz RL, Schneerson R, Robbins JB, Turck M. Urinary-tract escherichia coli with cross-reactive antigens to encapsulated pyogenic bacteria. Lancet (London, England). 2: 250-3. PMID 4114507 DOI: 10.1016/S0140-6736(72)91687-X |
0.543 |
|
| 1971 |
Schneerson R, Robbins JB. Age-related susceptibility to Haemophilus influenzae type b disease in rabbits Infection and Immunity. 4: 397-401. PMID 5317303 DOI: 10.1128/iai.4.4.397-401.1971 |
0.515 |
|
| 1971 |
Schulkind ML, Herzberg M, Robbins JB. Specific secondary biological properties of purified rabbit immunoglobulin M and immunoglobulin G antibodies to Brucella abortus and Bordetella pertussis. Infection and Immunity. 4: 220-7. PMID 4343404 DOI: 10.1128/iai.4.3.220-227.1971 |
0.324 |
|
| 1971 |
Bradshaw MW, Schneerson R, Parke JC, Robbins JB. Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b. Lancet (London, England). 1: 1095-6. PMID 4102623 DOI: 10.1016/S0140-6736(71)91837-X |
0.58 |
|
| 1970 |
Bradshaw M, Myerowitz RL, Schneerson R, Whisnant JK, Robbins JB. Pneumocystis carinii pneumonitis. Annals of Internal Medicine. 73: 775-7. PMID 5312205 DOI: 10.7326/0003-4819-73-5-775 |
0.449 |
|
| 1967 |
Robbins JB, Haimovich J, Sela M. Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose Immunochemistry. 4. PMID 6030410 DOI: 10.1016/0019-2791(67)90192-9 |
0.319 |
|
| Show low-probability matches. |